HHS on Friday delayed the start of a rule issued by former President Donald Trump's administration that would eliminate manufacturer drug rebates paid to pharmacy benefit managers and Medicare Part D plans, in today's bite-sized hospital and health industry news from California and the District of Columbia.
Medicare Part D, also known as the Medicare prescription drug benefit, is a voluntary program funded by CMS that subsidizes the costs of outpatient prescription drugs and prescription drug insurance premiums for Medicare patients.
Download the cheat sheet to learn why Medicare Part D a key issue for providers, how Medicare Part D works, and how Medicare Part D impacts provider-supplier sales relationships.
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
Never miss out on the latest innovative health care content tailored to you.